Systemic Treatments of Leishmaniasis: A Narrative Review

سال انتشار: 1398
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 386

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_RCM-6-3_002

تاریخ نمایه سازی: 16 مهر 1398

چکیده مقاله:

Cutaneous leishmaniasis is a prevalent parasitic infection in humans. According to the reports published in several localities across the world, leishmaniasis is an endemic disease in certain regions in Iran. Leishmaniasis is transmitted through sandfly bites and is often diagnosed through the smear examination of the affected area using a microscope. The treatments of choice for leishmaniasis involve the use of pentavalent antimony compounds, such as meglumine antimoniate and sodium stibogluconate. However, other medications have been proposed for the treatment of leishmaniasis, and there is ongoing research for effective, less harmful treatments. This narrative review aimed to summarize various systemic treatments for leishmaniasis.

کلیدواژه ها:

نویسندگان

Ahmad Reza Taheri

Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Sara Sabouri Rad

Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Sara Molkara

Resident of Dermatology, Imam Reza hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Alidadi S, Oryan A. Cutaneous leishmaniasis and the strategies for ...
  • Asgari Q, Motazedian MH, Mehrabani D, et al. Zoonotic cutaneous ...
  • Eiras DP, Kirkman LA, Murray HW. Cutaneous leishmaniasis: current treatment ...
  • Shirian S, Oryan A, Hatam GR, Daneshbod Y. Comparison of ...
  • van Griensven J, Gadisa E, Aseffa A, et al. Treatment ...
  • Daneshbod Y, Oryan A, Davarmanesh M,, et al. Clinical, histopathologic, ...
  • Oryan A, Mehrabani D, Owji SM, Motazedian MH, Asgari Q. ...
  • Yücel A, Günaşti S, Denli Y, et al. Cutaneous leishmaniasis: ...
  • Ameen M. Cutaneous leishmaniasis: therapeutic strategies and future directions. Expert ...
  • de Vries HJ, Reedijk SH, Schallig HD. Cutaneous leishmaniasis: recent ...
  • Foulet F, Botterel F, Buffet P, et al. Detection and ...
  • Hajjaran H, Vasigheh F, Mohebali M, et al. Direct diagnosis ...
  • Shahbazi F, Shahabi S, Kazemi B, Mohebali M, Abadi AR, ...
  • Andrade-Narvaez FJ, Medina-Peralta S, Vargas-Gonzalez A, et al. The histopathology ...
  • Bensoussan E, Nasereddin A, Jonas F, Schnur LF, Jaffe CL. ...
  • Frézard F, Demicheli C, Ribeiro RR. Pentavalent antimonials: new perspectives ...
  • Machado-Silva A, Guimarães PP, Tavares CA, et al. New perspectives ...
  • Ministry of Health and Medical Education. National Guideline for Cutaneous ...
  • Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect ...
  • Moreira VR de Jesus LCL, Soares RP, et al. Meglumine ...
  • Oliveira LF, Schubach AO, Martins MM, et al. Systematic review ...
  • Masmoudi A, Maalej N, Mseddi M, et al. Glucantime injection: ...
  • Belazzoug S, Neal RA. Failure of meglumine antimoniate to cure ...
  • Tuon FF, Amato VS, Graf ME, et al. Treatment of ...
  • Brajtburg J, Powderly WG, Kobayashi GS, et al: current understanding ...
  • Dupont B. Overview of the lipid formulations of amphotericin B. ...
  • Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years ...
  • Hamill RJ. Amphotericin B formulations: a comparative review of efficacy ...
  • Laniado-Laborín R, Cabrales-Vargas MN. Amphotericin B: side effects and toxicity. ...
  • Steimbach LM, Tonin FS, Virtuoso S, et al. Efficacy and ...
  • Tonin FS, Steimbach LM, Borba HH, et al. Efficacy and ...
  • Adler-Moore JP, Gangneux JP, Pappas PG. Comparison between liposomal formulations ...
  • Stone NR, Bicanic T, Salim R, et al. Liposomal Amphotericin ...
  • Wortmann G, Zapor M, Ressner R, et al. Lipsosomal amphotericin ...
  • Yardley V, Croft SL. A comparison of the activities of ...
  • Croft SL, Yardley V. Chemotherapy of Leishmaniasis. Curr Pharm Des ...
  • Guery R, Henry B, Martin-Blondel G, et al. Liposomal amphotericin ...
  • Goyonlo VM, Vosoughi E1, Kiafar B, et al. Efficacy of ...
  • Nikandish M, Goyonlo VM, Taheri AR. Ocular leishmaniasis treated by ...
  • Berman J. Miltefosine to treat leishmaniasis. Expert Opin Pharmacother. 2005;6:1381-1388. ...
  • Dorlo TP, Balasegaram M, Beijnen JH, et al. Miltefosine: a ...
  • Machado PR, Penna G. Miltefosine and cutaneous leishmaniasis. Curr Opin ...
  • Monge-Maillo B, López-Vélez R. Miltefosine for visceral and cutaneous leishmaniasis: ...
  • Vakil NH, Fujinami N, Shah PJ. Pharmacotherapy for leishmaniasis in ...
  • Mohebali M, Fotouhi A, Hooshmand B, et al. Comparison of ...
  • Chrusciak-Talhari A, Dietze R, Chrusciak Talhari C, et al. Randomized ...
  • Goa KL, Campoli-Richards DM.. Pentamidine isethionate. Drugs. 1987;33:242-258. ...
  • Sands M, Kron MA, Brown RB. Pentamidine: a review. Rev ...
  • Soeiro MN, Werbovetz K, Boykin DW, et al. Novel amidines ...
  • Hellier I, Dereure O, Tournillac I, et al. Treatment of ...
  • Soto J, Buffet P, Grogl M, et al. Successful treatment ...
  • Soto-Mancipe J, Grogl M, Berman JD. Evaluation of pentamidine for ...
  • van der Meide WF, Sabajo LO, Jensema AJ, et al. ...
  • Lai A Fat EJ, Vrede MA, Soetosenojo RM, et al. ...
  • Robledo SM, Puerta JA, Muñoz DL, et al. Efficacy and ...
  • Beach DH, Goad LJ, Holz GG Jr. Effects of antimycotic ...
  • Bodey GP. Azole antifungal agents. Clin Infect Dis. 1992;14:S161-169. ...
  • Odds FC, Brown AJ, Gow NA. Antifungal agents: mechanisms of ...
  • Zonios DI, Bennett JE. Update on azole antifungals. Semin Respir ...
  • Dogra J, Aneja N, Lal BB, et al. Cutaneous leishmaniasis ...
  • Cozzani E, Satta R, Fausti V, et al. Cutaneous sporotrichoid ...
  • Nassiri-Kashani M, Firooz A, Khamesipour A, et al. A randomized, ...
  • Freeman CD, Klutman NE, Lamp KC.. Metronidazole. A therapeutic review ...
  • Lamp KC, Freeman CD, Klutman NE, et al. Pharmacokinetics and ...
  • Mapar MA, Omidian M. Intralesional injections of metronidazole versus meglumine ...
  • Al-Waiz M, Sharquie KE, Al-Assir M. Treatment of cutaneous leishmaniasis ...
  • Belhadjali H, Elhani I, Youssef M, et al. Cutaneous leishmaniasis ...
  • Masmoudi A, Dammak A, Bouassida S, et al. Interest of ...
  • Bailey MS, Lockwood DN. Cutaneous leishmaniasis. Clin Dermatol. 2007;25:203-211. ...
  • Kellapatha I, Wijesinghe W, Ranatunga R, et al. Randomized double ...
  • Somaratne VN, Ranawaka RR, Jayaruwan HM, et al. Randomized, double-blind ...
  • Esfandiarpour I, Alavi A. Evaluating the efficacy of allopurinol and ...
  • Esfandiarpour I, Dabiri SH. Treatment of cutaneous leishmaniasis recidivans with ...
  • Momeni AZ, Aminjavaheri M. Successful treatment of non-healing cases of ...
  • Masmoudi A, Dammak A, Chaaben H, et al. Doxycycline for ...
  • Minodier P, Zambelli L, Mary C, et al. Cutaneous leishmaniasis ...
  • Silva-Vergara ML, Silva LdA, Maneira FRZ, et al. Azithromycin in ...
  • Lee SA, Hasbun R. Therapy of cutaneous leishmaniasis. Int J ...
  • Mayelifar K, Taheri AR, Rajabi O, et al. Ultraviolet B ...
  • Sazgarnia A, Taheri AR, Soudmand S, et al. Antiparasitic effects ...
  • نمایش کامل مراجع